KathleenN.S.CathcartMD

PubMed

• 154 citations
  A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.
  Kathleen Cathcart, Javier Pinilla-Ibarz, Tatyana Korontsvit, Joseph J. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg> ;Blood. 2004 Feb 1
• 175 citations
  Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
  Timothy B. Aliff, Peter G. Maslak, Joseph G. Jurcic, Mark L. Heaney, Kathleen N. Cathcart, Kent A. Sepkowitz, Mark A. Weiss> ;Cancer. 2003 Feb 15
• 5 citations
  Acute myeloid leukemia with t(5;18)(q35;q21)
  Eunice S. Wang, Peter Maslak, Kathleen Cathcart, Joseph G. Jurcic> ;Cancer Genetics and Cytogenetics. 2001 May 1
• 5 citations
  Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
  Joseph G. Jurcic, Kathleen Cathcart, Javier Pinilla-Ibarz, David A. Scheinberg> ;Current Opinion in Hematology. 2000 Jul 1
• 40 citations
  CML vaccines as a paradigm of the specific immunotherapy of cancer.
  Javier Pinilla-Ibarz, Kathleen Cathcart, David A. Scheinberg> ;Blood Reviews. 2000 Jun 1
• 200 citations
  Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
  Javier Pinilla-Ibarz, Kathleen Cathcart, Tatyana Korontsvit, Steven L. Soignet, Monica Bocchia, J. Caggiano, L. Lai, J. Jimenez, J. Kolitz, David A. Scheinberg> ;Blood. 2000 Mar 1
• 15 citations
  Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines
  Helene Z. Hill, Kathleen Nell Cathcart, Joseph Bargellini, Zoltan Trizna, George J. Hill, Karin U. Schallreuter, John M. Wood> ;Pigment Cell Research. 1991 Mar 1
• 64 citations
  Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide.
  Beverly A. Teicher, James M. Crawford, Sylvia A. Holden, Yawares J. Lin, Kathleen N. S. Cathcart, Carol A. Luchette, Jennifer L. Flatow> ;Cancer. 1988 Oct 1
• 15 citations
  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo
  Beverly A. Teicher, Terence S. Herman, Sylvia A. Holden, Kathleen N. S. Cathcart> ;Cancer Chemotherapy and Pharmacology. 1988 Jun 1
• 14 citations
  Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
  Beverly A. Teicher, Samuel D. Bernal, Sylvia A. Holden, Kathleen N. S. Cathcart> ;Cancer Chemotherapy and Pharmacology. 1988 Jan 1
• Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
  Teicher BA, Crawford JM, Holden SA, Cathcart KN> ;Cancer Res.. 1987-10-01
• 22 citations
  Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays.
  Beverly A. Teicher, Sylvia A. Holden, Kathleen N. S. Cathcart> ;International Journal of Radiation Oncology, Biology, Physics. 1987 Aug 1
• Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
  Eder JP, Teicher BA, Holden SA, Cathcart KN, Schnipper LE> ;J. Clin. Invest.. 1987-05-01
• Some complexes of cobalt(III) and iron(III) are radiosensitizers of hypoxic EMT6 cells.
  Teicher BA, Jacobs JL, Cathcart KN, Abrams MJ, Vollano JF, Picker DH> ;Radiat. Res.. 1987-01-01
• Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloro...
  Herman, T. S., Teicher, B. A., Cathcart, K. N., Kaufmann, M. E., Lee, J. B., Lee, M. H.> ;Cancer Res. 1988 Sep 15
• Preclinical studies and clinical correlation of the effect of alkylating dose.
  Frei, E., Teicher, B. A., Holden, S. A., Cathcart, K. N., Wang, Y. Y.> ;Cancer Res. 1988 Nov 15
• Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
  Teicher, B. A., Holden, S. A., Cucchi, C. A., Cathcart, K. N., Korbut, T. T., Flatow, J. L., Frei, E.> ;Cancer Res. 1988 Jan 1
• Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
  Eder, J. P., Teicher, B. A., Holden, S. A., Cathcart, K. N., Schnipper, L. E., Frei, E.> ;Cancer Res. 1989 Feb 1
• Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
  Teicher, B. A., Holden, S. A., Cathcart, K. N., Herman, T. S.> ;J Natl Cancer Inst. 1988 Jun 15
• Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodo...
  Eder, J. P., Teicher, B. A., Holden, S. A., Senator, L., Cathcart, K. N., Schnipper, L. E.> ;Cancer Chemother Pharmacol. 1990
• Join now to see all